SIP 1.55% $1.31 sigma pharmaceuticals limited

sell down, page-5

  1. 3,055 Posts.
    lightbulb Created with Sketch. 127
    Not sure if SIP is going to down grade earning, the annual meeting was just a month ago but I could be wrong.
    I think the main reason is few institutional investors have sold out and SIP has not been successful in a few takeovers.

    It was rumoured a few months ago that SIP was going to conduct an on market buyback. If they were ever going to do that probably will be now.

    I think what ever happens SIP is still a long term buy.

    Just my opinion do your own research.

 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.